Contineum Therapeutics, Inc. (NASDAQ:CTNM) Short Interest Update
MarketBeat
Contineum Therapeutics, Inc. (NASDAQ:CTNM - Get Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 620,600 shares, an increase of 42.6% from the August 15th total of 435,200 shares. Based on an average daily trading volume, of 258,700 shares, the short-interest ratio is presently 2.4 days. Approximately 4.0% of the shares of the stock are short sold. Approximately 4.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 258,700 shares, the short-interest ratio is presently 2.4 days.
NASDAQ:CTNM
